Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Dec 3;9(1):18243.
doi: 10.1038/s41598-019-54342-4.

Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla

Affiliations
Multicenter Study

Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla

Wolfgang Rudolf Bauer et al. Sci Rep. .

Abstract

Magnetic resonance imaging (MRI) has long been contraindicated in patients with implanted pacemakers, defibrillators, and cardiac resynchronisation therapy (CRT) devices due to the risk of adverse effects through electromagnetic interference. Since many recipients of these devices will have a lifetime indication for an MRI scan, the implantable systems should be developed as 'MRI-conditional' (be safe for the MRI environment under predefined conditions). We evaluated the clinical safety of several Biotronik ProMRI ('MRI-conditional') defibrillator and CRT systems during head and lower lumbar MRI scans at 1.5 Tesla. The study enrolled 194 patients at 22 sites in Australia, Canada, and Europe. At ≥9 weeks after device implantation, predefined, non-diagnostic, specific absorption rate (SAR)-intensive head and lower lumbar MRI scans (total ≈30 minutes per patient) were performed in 146 patients that fulfilled pre-procedure criteria. Three primary endpoints were evaluated: freedom from serious adverse device effects (SADEs) related to MRI and defibrillator/CRT (leading to death, hospitalisation, life-threatening condition, or potentially requiring implanted system revision or replacement), pacing threshold increase, and sensing amplitude decrease, all at the 1-month post-MRI clinical visit. No MRI-related SADE occurred. Lead values remained stable, measured in clinic and monitored daily by the manufacturer home monitoring technology.

PubMed Disclaimer

Conflict of interest statement

W.B. is scientific advisor of Biotronik. D.H.L. is supported by a Robert J. Craig Lectureship from the University of Adelaide and received lecture and/or consulting fees from St Jude Medical, Boehringer Ingelheim, Bayer, and Pfizer. A.McG. received support from Biotronik to attend past meetings (travel and accommodation). S.F. is employee of Biotronik. Other authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study. FU: follow-up; MRI: magnetic resonance imaging.
Figure 2
Figure 2
Isocentres at eye and hip level of magnetic resonance imaging scans, the available area for the scans (≈50 cm × 50 cm), and the scan exclusion zone. The size of the usually quadratic field of view varied with body region, scanner manufacturer (Siemens, Philips, GE), and the type of scan sequence (Table 2). The most common field of view was 23 cm × 23 cm, resulting in greater magnetic field gradients and thus more compelling testing conditions than it would be for a larger (e.g. 50 cm × 50 cm) field of view.

Similar articles

Cited by

References

    1. Nordbeck P, Ertl G, Ritter O. Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? Eur. Heart J. 2015;36:1505–1511. doi: 10.1093/eurheartj/ehv086. - DOI - PMC - PubMed
    1. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin. Electrophysiol. 2005;28:326–328. doi: 10.1111/j.1540-8159.2005.50024.x. - DOI - PubMed
    1. Wilkoff BL, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. 2011;8:65–73. doi: 10.1016/j.hrthm.2010.10.002. - DOI - PubMed
    1. Wollmann CG, Steiner E, Vock P, Ndikung B, Mayr H. Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead. J. Cardiovasc. Magn. Reson. 2012;14:67. doi: 10.1186/1532-429X-14-67. - DOI - PMC - PubMed
    1. Gimbel JR, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. 2013;10:685–691. doi: 10.1016/j.hrthm.2013.01.022. - DOI - PubMed

Publication types